key: cord-0815490-sisakzmo
authors: da Silva, Andressa Chang Rodrigues Fernandes; Pereira, Luanderson Lopes; Lemos, Felipe Barreto; Machado, Fernanda Conceição; Figueiredo, Andreia Leal
title: Would periodontitis be a facilitating factor for COVID‐19 progression?
date: 2021-03-22
journal: Oral Dis
DOI: 10.1111/odi.13846
sha: 4f0f5fc4a00d80bb9100888317a287de4fc7b7eb
doc_id: 815490
cord_uid: sisakzmo

nan

The pandemic caused by the new coronavirus (SARS-CoV-2) has led to an exponential increase in scientific publications about the symptoms, virulence potential, risk of infection, and particularly methods for the treatment and prevention of the disease called COVID-19 (PAHO, 2020).

We are seeing different hypotheses that have been raised to explain the interaction between the virus and periodontitis, including the approaches taken by Martín Carreras-Presas et al., (2020) and Patel and Woolley (2020) . However, because this viral agent is so new, there are no clinical or population studies with greater power of scientific evidence to prove this association.

When inflamed, periodontal tissues undergo several changes in their shape and structure and should, therefore, be investigated in the active form of the disease. Pfützner et al., (2020) believe that epithelial mucosal ulceration caused by periodontitis leads to the loss of protection against viral agents, which can render the individual with periodontitis more vulnerable to SARS-CoV-2 infection.

Some studies suggest that molecular factors present in the healthy oral mucosa may facilitate the interaction between the virus and host cells. Angiotensin-converting enzyme 2 (ACE-2) present in fibroblasts of the periodontal ligament and in the gums has an affinity for the SARS-CoV-2 virus, which easily penetrates the target cells. Therefore, all cells that express ACE-2 are susceptible to infection (Madapusi Balaji et al., 2020) . Wu and Yang (2020) demonstrated increased production of these cytokines in the blood of patients with moderate and severe COVID-19. Thus, the increase in serum interleukins may be linked to worsening of the disease . Within the context of preventing possible respiratory complications in patients with COVID-19, the absence of other inflammatory factors such as periodontitis would be extremely important. In the case of patients with active periodontitis, periodontal treatment proved to be efficient in reducing serum levels of IL-17 (Cheng et al., 2014) . Hence, it is possible that periodontal treatment of patients with COVID-19 may also decrease these blood interleukins, attenuating the pulmonary inflammatory response.

Another physiological mechanism of periodontitis that might be associated with COVID is related to neutrophil extracellular traps (NETs). NETs represent an alternative form of cell death that causes tissue damage directly or indirectly through immune mechanisms Periodontitis triggers the production of NETs by activating interferon-alpha. Cell death via NETs can also be stimulated by viruses such as SARS-CoV-2. Exacerbation of NET production is observed in more advanced stages of COVID-19, which may be linked to the development of a hyper-inflammatory state called "cytokine storm" (Mozzini & Girelli, 2020) .

The available studies are still not sufficient to answer how periodontitis interacts with SARS-CoV-2, although there is theoretical evidence of how these two pathologies are likely to be associated.

Clinical, experimental and longitudinal approaches are particularly useful to provide reliable scientific evidence in the current pandemic scenario.

ACRFS and FBL are funded by the Coordination for the Improvement of Higher Education Personnel (CAPES); FCM is funded by the Fundação de Amparo à Pesquisa do Estado da Bahia (FAPESB) but the views expressed are those of the authors and not necessarily those of CAPES and FAPESB.

The presence, function and regulation of IL-17 and Th17 cells in periodontitis

The intriguing commonality of NETosis between COVID-19 & Periodontal disease

Oral cancer and periodontal disease increase the risk of COVID 19? A mechanism mediated through furin and cathepsin overexpression

SARS-CoV-2 oralassociated lesions: Discussion of elicited response

The role of Neutrophil Extracellular Traps in Covid-19: Only an hypothesis or a potential new field of research?

COVID-19 Pandemic: statistics on access to the VHL and the extent of BIREME's technical cooperation

Necrotizing periodontal disease: Oral manifestation of COVID-19

Why do people with diabetes have a high risk for severe COVID-19 disease?-A dental hypothesis and possible prevention strategy

COVID-19 & Periodontitis: The cytokine connection

TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib

Would periodontitis be a facilitating factor for COVID-19 progression